SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
37 hedge funds and large institutions have $14.2M invested in Sigilon Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 17 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
37
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$256K | |
| 2 | +$59K | |
| 3 | +$39.9K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$15K |
Top Sellers
| 1 | -$538K | |
| 2 | -$212K | |
| 3 | -$148K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$104K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$77.3K |